Jutba, Feliciano .
HRN: 05-51-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/20/2023
07/27/2023
IV
4.5g
Q8hr
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes